Our five Research Centres are tackling some of the major global health challenges facing our society and addressing fundamental questions about how we work to gain a better understanding of how we can treat disease and repair our bodies.
CCNS conducts research on the neurobiology of both normal cognition and disorders of cognition, particularly Fragile-X and Alzheimer’s Disease, using state-of-the-art techniques.
We research fundamental physiological mechanisms and pathways, from single genes to complex behaviour, relevant to normal human function and how disruption of these mechanisms lead to disease.
The Centre seeks to understand the mechanisms of neural development, injury and repair.
Our work integrates genomic science and systems biology with medicine and physical sciences, for understanding and innovating host-directed diagnosis and treatment of acquired diseases. We are committed to bringing these new approaches to the developing world.
The Centre seeks to understand the neurological basis of, and to test new therapies for, autism, Fragile X Syndrome and intellectual disabilities.
We contribute to interdisciplinary research with the following Institutes;
Edinburgh Infectious Diseases is a network of Infectious Disease scientists in Edinburgh, working to maximise synergy within research, teaching and public engagement.
Edinburgh Neuroscience seeks to integrate basic and clinical research in order to drive the fundamental genetic, cellular, organ, systems and computational neuroscience underpinning pathogenesis into mechanistic understanding, future diagnostics and therapeutics of important diseases of the nervous system.
We also contribute to interdisciplinary research with the following Centres;
The Muir Maxwell Epilepsy Centre aims to investigate the causes of childhood epilepsy and to develop new treatments and public health strategies.
The major research interests of the Unit are of the cardiovascular system in cardiovascular disease, and clinical toxicology.